Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation
Open Access
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Stem Cell Research
- Vol. 31, 147-151
Abstract
No abstract availableKeywords
Funding Information
- Retina Australia
This publication has 5 references indexed in Scilit:
- The CRB1 Complex: Following the Trail of Crumbs to a Feasible Gene Therapy StrategyFrontiers in Neuroscience, 2017
- High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem CellsStem Cell Reports, 2017
- CRB1 : One Gene, Many PhenotypesSeminars in Ophthalmology, 2013
- Efficient Stage-Specific Differentiation of Human Pluripotent Stem Cells Toward Retinal Photoreceptor CellsStem Cells, 2012
- CRB1 mutations may result in retinitis pigmentosa without para-arteriolar RPE preservationOphthalmic Genetics, 2001